Description
Changa: Neuroactive Herbal Blend
Changa is a meticulously formulated herbal preparation combining N,N-Dimethyltryptamine (DMT) with monoamine oxidase inhibitors (MAOIs) derived from botanicals such as Banisteriopsis caapi. This synergistic blend enhances DMT’s bioavailability, extending its psychoactive effects when smoked or vaporized. Designed for researchers, neuroscientists, and experienced users studying altered states of consciousness, Changa offers a controlled, reproducible platform for exploring the neurochemical and perceptual effects of serotonergic psychedelics. Its composition includes inert carrier herbs (e.g., mullein, peppermint) to optimize combustion and flavor, delivering a consistent and efficient administration.
Pharmacological Profile and Subjective Effects Changa’s primary active components are DMT, a potent 5-HT2A receptor agonist, and harmala alkaloids (e.g., harmine, harmaline) from MAOIs, which inhibit the breakdown of DMT in the body. Upon inhalation, effects onset within 10-30 seconds, peaking at 3-10 minutes and subsiding within 15-20 minutes. Users report dose-dependent perceptual changes, including vivid visual hallucinations (e.g., geometric patterns, fractals), altered time perception, and heightened emotional introspection. Higher doses may induce profound dissociative states, characterized by immersive imagery and abstract cognitive shifts. Post-experience effects often include elevated mood and cognitive clarity, with minimal physical aftereffects. The extended duration compared to freebase DMT allows for more structured observation of subjective phenomena.
Dosing Recommendations.
Low Dose (10-25 mg): Sub-perceptual to mild effects, including enhanced sensory acuity, slight visual distortions, and cognitive stimulation. Suitable for initial trials or neurophenomenological studies.
-
Moderate Dose (25-50 mg): Pronounced visual and auditory hallucinations, emotional amplification, and altered self-perception. Recommended for users with prior psychedelic experience in controlled settings.
-
High Dose (50-100 mg): Intense, immersive psychoactive states, potentially including dissociation, complex visual phenomena, and abstract ideation. Reserved for advanced users in clinical or ceremonial contexts with supervision.
Administer via a glass pipe or vaporizer, inhaling slowly and holding for 10-15 seconds to maximize absorption. Use a milligram scale for accuracy. Conduct experiments in a distraction-free environment with a trained observer for higher doses.
Product Specifications
-
Composition: DMT-infused herbal matrix (e.g., mullein, peppermint) combined with MAOI-containing botanicals (e.g., Banisteriopsis caapi). Standardized for consistent DMT and harmala alkaloid ratios.
-
Packaging: Available in 0.5g ($94.99) light-resistant pouches to ensure stability.
-
Quality Control: Third-party lab-tested for purity and alkaloid content. Sourced from ethically managed suppliers, free of contaminants or synthetic additives.
-
Storage: Store at room temperature in a dry, dark environment to maintain chemical integrity.
Safety and Contraindications Changa is a potent psychoactive compound and should be approached with caution. It is contraindicated for individuals using SSRIs, SNRIs, or other MAOI-interacting medications due to risks of serotonin syndrome. Avoid use in cases of cardiovascular disease, hypertension, or severe psychiatric conditions (e.g., schizophrenia). Pre-screening for medical history and psychological stability is advised. Post-administration integration (e.g., structured reflection, data logging) enhances the scientific value of the experience.
